Pilot or pivotal ? [General Sta­tis­tics]

posted by Ohlbe – France, 2018-06-27 15:43 (1259 d 20:01 ago) – Posting: # 18981
Views: 10,847

Hi ElMaestro,

» This is purely hypothetical for me. As far as I recall, I have not ever faced such a situation where two test formulations targeting the same authority were heads-on compared in a pivotal trial. I have faced it numerous times in pilot trials, but here the choice of formulation rarely is based on the CI but just on the observed GMR.

Precisely. But then, isn't this whole discussion on alpha correction purely hypothetical too ?

Sorry if I'm spoiling a nice thread...

Regards
Ohlbe

Complete thread:

Activity
 Admin contact
21,788 posts in 4,557 threads, 1,548 registered users;
online 7 (0 registered, 7 guests [including 4 identified bots]).
Forum time: Wednesday 10:45 CET (Europe/Vienna)

There is no adequate defense, except stupidity,
against the impact of a new idea.    Percy Williams Bridgman

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5